RehaBEElitation - Serious Game-Based Experimental Protocol to Improve Manual Dexterity in Individuals With Parkinson's Disease

What this study involves

The registry does not currently label this study as recruiting. Ask about its status before planning a screening visit.

Study type

Interventional

Phase

Not applicable

Age range

40 years - 100 years

Sex eligible

All sexes

Healthy volunteers

Not accepted

Participants

27 Actual

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

This is a non-randomized controlled trial with two parallel groups, with the general objective of developing and applying an assessment and intervention protocol based on a serious game for the rehabilitation of hand function in individuals with Parkinson's disease (PD). The experimental group trained with the RehaBEElitation serious game, controlled by hand and wrist movements through a wearable sensor glove; the control group trained the same five movements with a home exercise booklet. Both groups trained twice a week for six weeks (12 sessions of 30 to 45 minutes) and kept their usual physiotherapy. Participants were allocated in sequence: those enrolled first received the serious game and those enrolled later received the booklet. Manual dexterity, motor signs, quality of life, functioning and upper-limb muscle activation (surface electromyography) were assessed before and after the intervention. This trial was registered retrospectively.

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

• Diagnosis of Parkinson's disease confirmed by a neurologist or geriatrician
• Age between 40 and 100 years
• Mild to moderate disease (Hoehn \& Yahr stages I to III)
• Mini-Mental State Examination score above 25
• No severe visual (Snellen chart) or hearing impairment
• No other neurological or musculoskeletal disease
• Functional and body-structure requirements for the training, assessed with the ICF checklist
• Read and agreed to the informed consent form

Exclusion Criteria:

• Uncontrolled hypertension, unstable angina or recent myocardial infarction
• History of seizures
• Participation in another clinical trial involving rehabilitation or an experimental drug
• Missing more than three sessions or withdrawing from the intervention

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment

Not randomized

Masking

No masking

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

Research locations (1)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

1 locations

Study team and timeline

Lead sponsor

Federal University of Uberlandia

Study start

Oct 24, 2023 Actual

Primary completion

Nov 5, 2024 Actual

Study completion

Nov 5, 2024 Actual

First posted

Nov 10, 2026 Actual

Last updated

Nov 10, 2026 Actual

Official study contacts

No central contact is listed. Check the locations and the official record.